Sunrun Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains Overweight on Sunrun, Lowers Price Target to $12
Sunrun Analyst Ratings
Wells Fargo Maintains Sunrun(RUN.US) With Buy Rating, Cuts Target Price to $12
BNP Paribas Exane Upgrades Sunrun to Outperform From Neutral, Raises Price Target to $16 From $14
BNP Paribas Upgrades Sunrun(RUN.US) to Buy Rating, Raises Target Price to $16
TD Cowen Initiates Sunrun(RUN.US) With Buy Rating, Announces Target Price $21
Sunrun (RUN) Receives a New Rating From TD Cowen
TD Cowen Initiates Coverage on Sunrun With Buy Rating, $21 Price Target
Sunrun Analyst Ratings
Goldman Sachs Maintains Sunrun(RUN.US) With Buy Rating, Announces Target Price $17
RBC Capital Maintains Sunrun(RUN.US) With Buy Rating, Cuts Target Price to $17
RBC Capital Remains a Buy on Sunrun (RUN)
Sunrun Is Maintained at Neutral by UBS
Sunrun Analyst Ratings
UBS Maintains Sunrun(RUN.US) With Hold Rating, Cuts Target Price to $14
Piper Sandler Maintains Sunrun(RUN.US) With Hold Rating, Maintains Target Price $11
Piper Sandler Downgrades Sunrun(RUN.US) to Hold Rating, Cuts Target Price to $11
Sunrun Downgraded to Neutral From Overweight at Piper Sandler
Sunrun Is Maintained at Overweight by Morgan Stanley